Thomas R. Cox, Feb 2017
Our new paper on the pre-clinical testing of two novel potential anti-cancer drugs in breast cancer has just been published in Oncotarget.
We are delighted to welcome our newest member, Joanna Skhinas, to the Matrix and Metastasis lab here at the Kinghorn Cancer Centre and Garvan Institute.
Joanna joins us as a research assistant having recently completed her Honours degree at the University of New South Wales. Joanna will work on our recently awarded NHMRC grant to understand more about how the stiffness of the extracellular matrix affects cancer progression and response to therapy.
Through joining our team, Joanna can pursue her “interest in cancer biology, in particular the interactions between cancer cells and the surrounding extracellular matrix, and the ECMs role in metastasis”
Our new protocol on in vitro shear rheology of cell-embedded hydrogels has just been published in bio-protocol
Bio-protocol (ISSN: 2331-8325) is a peer-viewed e-journal established in 2011 by a group of Stanford researchers. Their mission is to make life science research more efficient and reproducible by curating and hosting high quality, open access, life science protocols.
We’re delighted to announce the we have been awarded a New Investigator Project Grant from the National Health and Medical Research Council (NHMRC).
The grant will support a project investigating how targeting tumour tissue stiffness can increase the efficacy of currently approved therapies in solid cancers. Continue reading
Thomas R. Cox, Dec 2016
We are seeking a full-time dedicated research assistant to work in the Cancer Division Matrix & Metastasis Group headed by Dr. Thomas Cox. The group combines the use of 3D models of cancer with novel state-of-the-art imaging approaches to reveal how the extracellular matrix drives cancer progression and metastasis. Our mission is to establish targeting of the extracellular matrix as a viable therapeutic approach in the treatment of solid cancers. Continue reading
Thomas R. Cox, Nov 2016
It is an absolute honour to announce that I was awarded the Journal of Biological Chemistry (JBC) Herbert Tabor Young Investigator Award at the 2016 Matrix Biology Society of Australia and New Zealand (MBSANZ) conference.
The JBC Herbert Tabor Young Investigator Awards are meant to honour Dr. Tabor’s invaluable contributions to the journal and to science as a whole. The awards recognise the innovators and achievers in new generations of researchers who exemplify his values of creativity and scientific excellence. Continue reading
Thomas R. Cox, Oct 2016
I’m delighted to have been invited to speak at the upcoming 8th Garvan Signalling Symposium being held at the Garvan Institute of Medical Research in Sydney, Australia from 31st October – 1st November.
This is a short two day international symposium focusing on many different aspects of signalling across a wide range of tissues and organisms in both health and disease.
Our new article as part of a special issue of the Journal of Bone Oncology focusing on The role of the microenvironment in bone metastasis is now out:
I recently attended the MRS 16th Biennial Meeting in China Chengdu, which was a fantastic conference and brought together some of the best cancer metastasis researchers in the world to discuss current and future work in the field.
The congress, co-organized by Qinghua Zhou of the Chinese Tumor Metastasis Society and Yibin Kang of the Metastasis Research Society took place from the 16th-20th of September 2016 and made national news in China, including interviews with incoming MRS president, Yibin Kang, and outgoing MRS president, Jonathan Sleeman.
Thomas R. Cox, Sep 2016
I’m delighted to say that I have been elected as Chair of the Early Career Leadership Council (ECLC) of the Metastasis Research Society (MRS) and will begin my term with immediate effect.
The Early Career Leadership Council (ECLC) is the representative body of the early career members of the Metastasis Research Society (MRS).
The Early Career Leadership Council of the MRS concept was created and formalized in 2011, and is open to graduate students, medical students and residents, and clinical and postdoctoral fellows who are enrolled in educational or training programs leading to careers in cancer metastasis research. Continue reading